CHRS Member Lead High Impact Publications
- Verma A, Birnie DH, Jiang C, et al. Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation. N Engl J Med. 2026;394(4):323-332.
- Joza J, Philippon F, Chew DS, et al. Current Challenges in Cardiac Device Management: Guidance for Practicing Clinicians: A Canadian Journal of Cardiology White Paper. Can J Cardiol. 2026;42(1):101-135.
- Rivard L, Khairy P, Talajic M, et al. Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial. Nat Med. 2026;32(1):297-305.
- Andrade JG, Joza J, Chew DS, et al. The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic Devices. Can J Cardiol. 2026;42(1):1-68.
- Sapp JL, Tang ASL, Parkash R, et al. Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. N Engl J Med. 2025;392(8):737-747.
- Demonceaux M, Benseba J, Ruiz M, et al. Right Ventricular Remodeling in Complex Congenital Heart Disease. Can J Cardiol. 2025;41(6):1067-1080.
- Aydin A, Golian M, Klein A, et al. Iodinated Adhesive Drapes for Repeat Cardiac Implantable Device Implantation: A Randomized Clinical Trial. JAMA Cardiol. 2025;10(10):1016-1023.
- Sang C, Liu Q, Lai Y, et al. Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF: The PROMPT-AF Randomized Clinical Trial. JAMA. 2025;333(5):381-389.
- Jolly SS, d'Entremont MA, Pitt B, et al. Routine Spironolactone in Acute Myocardial Infarction. N Engl J Med. 2025;392(7):643-652.
- Andrade JG, Virani A, Staunton A, et al. Navigating the Landscape of Medical Device Advisories: A Special Report From the Canadian Heart Rhythm Society Device Advisory Committee. Can J Cardiol. 2024;40(11):2106-2116.
- Knops RE, Lloyd MS, Roberts PR, et al. A Modular Communicative Leadless Pacing-Defibrillator System. N Engl J Med. 2024;391(15):1402-1412.
- Oraii A, McIntyre WF, Parkash R, et al. Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. JAMA Cardiol. 2024;9(6):545-555.
- Sapp JL, Sivakumaran S, Redpath CJ, et al. Long-Term Outcomes of Resynchronization-Defibrillation for Heart Failure. N Engl J Med. 2024;390(3):212-220.
- Shurrab M, Austin PC, Jackevicius CA, et al. Comparative effectiveness and safety of apixaban and rivaroxaban in older patients with atrial fibrillation: A population-based cohort study. Heart Rhythm. 2024;21(12):2397-2406.
- McIntyre WF, Benz AP, Becher N, et al. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Circulation. 2024;149(13):981-988.
- Healey JS, Lopes RD, Granger CB, et al. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. N Engl J Med. 2024;390(2):107-117.
- Johnson LS, Mente A, Joseph P, et al. Sodium Intake and Incident Atrial Fibrillation in Individuals With Vascular Disease. JAMA Netw Open. 2024;7(7):e2421589.
- Conen D, Ke Wang M, Popova E, et al. Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial. Lancet. 2023;402(10413):1627-1635.
- Wilkoff BL, Filippatos G, Leclercq C, et al. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial [published correction appears in Lancet. 2023 Sep 30;402(10408):1132.
- Boursalie S, MacIntyre C, Sapp JL, et al. Disparities in Referral and Utilization of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death. Can J Cardiol. 2023;39(11):1610-1616.